Cure Ventures
Overview
Cure Ventures is a life sciences venture capital firm focusing on de novo company formation around groundbreaking curative technologies. The firm focuses on early-stage investments in life science and biotechnology, primarily focused in new therapeutics. Cure's unique approach also embraces genetic validation as part of an iterative process to guide a drug through development, increasing the probability of success and mitigating the cost of failure. Embedded Cure operators work alongside portfolio company founders to drive day-to-day decision making.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kenai Therapeutics | Feb 2024 | Series A | Lead |
| Triton Therapeutics, Inc. | Oct 2025 | Seed | Co-investor |
| Tortugas Neuroscience | Aug 2026 | Series A | Co-investor |
| Clasp Therapeutics | Mar 2024 | Series A | Co-investor |
| Oatmeal Health | Feb 2024 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Richard Lim
Managing Partner And Co-Founder
Albert J Robichaud
Partner
Annie Mitsak
Partner
Jeffrey Jonas
Partner
Jeno Gyuris
Partner
Kenzie MacIsaac
Partner
May Han
Partner
milenko cicmil
Partner
Bill Amsbaugh
Chief Technology Officer, Partner
Drew King
Partner And Chief Financial Officer
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cure Ventures based?
Cure Ventures is headquartered in Boston, Massachusetts, United States.
When was Cure Ventures founded?
Cure Ventures was founded in 2021.
How many portfolio companies does Cure Ventures have?
Cure Ventures has 10 portfolio companies in Caplight's dataset.
What are some companies in Cure Ventures's portfolio?
Portfolio companies visible on Caplight include Kenai Therapeutics, Triton Therapeutics, Inc., Tortugas Neuroscience, Clasp Therapeutics, Oatmeal Health.
What was Cure Ventures's most recent investment shown here?
Cure Ventures's most recent investment in this portfolio sample was in Tortugas Neuroscience in 2026.
What sectors does Cure Ventures focus on?
Cure Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Cure Ventures focus on?
Cure Ventures typically invests at the Early stage.
What is Cure Ventures's AUM?
Cure Ventures's assets under management are estimated between $250.0M and $500.0M.